Neurology Specific Literature Search   
 
[home][thesaurus]
    

Differential
(Click to cross reference)
advances in neurology
adverse drug reaction
agitation
Alzheimer's disease
Alzheimer's disease, diagnosis of
Alzheimer's disease, pathogenesis
Alzheimer's disease, preclinical
Alzheimer's disease, risk factors in
Alzheimer's disease, treatment of
Alzheimer's disease, vaccine
amyloid
amyloid angiopathy, cerebral
amyloid angiopathy, cerebral, inflammatory type
amyloid beta protein
amyloid beta protein antibodies
amyloid beta-related angiitis
amyloid deposition
amyloid imaging
amyloid plaques
amyloidosis
angiitis
angiitis, granulomatous of CNS
angiitis, isolated of CNS
angiography, cerebral
angiography, cerebral, false negative
angiography, cerebral, negative
anti-amyloid therapy
aphasia
apolipoprotein E
areflexia
asymptomatic
ataxia
ataxia, cerebellar
ataxia, hereditary
biologic markers
brain biopsy
carotid artery, enlarged external diameter
CAT scan
CAT scan, emission
CAT scan, emission, abnormal
CAT scan, false negative
central nervous system, infection of
cerebellar atrophy, primary
cerebellar atrophy, secondary
cerebellar degeneration
cerebellar plaques, amyloid
cerebral cortical atrophy
cerebrospinal fluid, abnormal
cerebrospinal fluid, biochemical markers of CNS disease
cerebrospinal fluid, elevated protein of
cerebrovascular accident
Clinical Pathologic Conference(C.P.C.)
cognition
confusion
deep learning
degenerative diseases of CNS
delusion
dementia
dementia, diagnostic evaluation of
dementia, early detection
dementia, familial
dementia, presenile
dementia, prevention of
dementia, reversible
dementia, transmissible
dementia, treatment of
depression
differential diagnosis
disease modifying agents
disorientation
donanemab
dyspraxia
echolalia
efficacy
electroencephalogram
electroencephalogram, abnormalities of
endocarditis, native-valve
familial
fatal familial insomnia
florbetapir
genetic neurologic disorders
Gerstmann-Straussler-Scheinker disease
grasping
head injury
headache
hippocampal atrophy
histochemistry
immunosuppressive agents
intellectual deterioration
intracerebral hemorrhage
intranasal medication
Jakob-Creutzfeldt disease
kuru
laughing, pathologic
machine learning
memory, impairment of
meningeal enhancement
mental status, abnormal
microhemorrhage, intracerebral
microhemorrhage, intracerebral, location
mild cognitive impairment
mild cognitive impairment converting to Alzheimer's disease
molecular genetics
mongolism
monoclonal antibodies
movement disorder
MRI
MRI, abnormal
MRI, contrast enhanced
MRI, disappearing lesion on
MRI, functional
MRI, gradient-echo
MRI, vessel wall
MRI, vessel wall enhancement
MRI, volumetry
multinucleated giant cell
myoclonic jerks
myoclonus
negative
neurofibrillary degeneration
neurologic disease, diagnoses of
neurologic symptoms
neuropathology
neuropathology, brain
normal
old age, neurology of
Parkinson disease
Parkinsonism syndrome
pathology
Pittsburgh Compound B
pleocytosis of cerebrospinal fluid
preclinical
prevention of neurologic disorders
prion disease
psychosis
pursuit eye movements, abnormal
pyramidal tract dysfunction
reversible cerebral vasoconstrictive syndromes
review article
risk factors
safety
seizure
senile plaques
single photon emission computed tomography
spongy degeneration of brain
startle myoclonus
steroid therapy, CNS treatment and complications with
tau protein
temporal lobe
TRAILBLAZER-ALZ trial
treatment of neurologic disorder
vaccine
vasculitides
virus, slow
visual loss
visual symptoms
weakness, focal
weight loss
white matter disease
Showing articles 0 to 50 of 345 Next >>

Donanemab in Early Symptomatic Alzheimer Disease, The TRAILBLAZER-ALZ 2 Randomized Clinical Trial
JAMA 330:512-517, 510, Sims,J.R.,et al, 2023

Application of Deep Learning to Predict Standardized Uptake Value Ratio and Amyloid Status on 18F-Florbetapir PET Using ADNI Data
AJNR 41:980-986, Reith, F.,et al, 2020

Prevalence of Cerebral Amyloid Pathology in Persons without Dementia
JAMA 313-1924-1938,1913, Jansen, W.J.,et al, 2015

Prevalence of Amyloid PET Positivity in Dementia Syndromes
JAMA 313:1939-1949,1913, Ossenkoppele, R.,et al, 2015

Antiamyloid Therapy for Alzheimers Disease - Are We on the Right Road?
NEJM 370:377-378, Karran, E. & Hardy, J., 2014

Predicting sites of New Hemorrhage with Amyloid Imaging in Cerebral Amyloid Angiopathy
Neurol 79:320-326, Gurol, M.E.,et al, 2012

Adult Primary Central Nervous System Vasculitis
Lancet 380:767-777, Salvarani, C.,et al, 2012

Brain Amyloid Imaging - FDA Approval of Florbetapir F18 Injection
NEJM 367:885-887, Yang, L.,et al, 2012

In Vivo Mapping of Amyloid Toxicity in Alzheimer Disease
Neurol 72:1504-1511, Frisoni,B.G.,et al, 2009

Conversion of Amyloid Positive and Negative MCI to AD over 3 Years: An 11C-PIB PET Study
Neurol 73:754-760, 744, Okello,A.,et al, 2009

DNA �-Amyloid1-42 Trimer Immunization for Alzheimer Disease in a Wild-Type Mouse Model
JAMA 302:1796-1802, Lambracht-Washington,D.,et al, 2009

Pittsburg Compound B Imaging and Prediction of Progression From Cognitive Normality to Symptomatic Alzheimer Disease
Arch Neurol 66:1469-1475, Morris,J.,et al, 2009

Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Arch Neurol 65:1509-1517, Aizenstein,H.J.,et al, 2008

Long-Term Effects of A�42 Immunisation in Alzheimers Disease: Follow-Up of a Randomised, Placebo-Controlled Phase I Trial
Lancet 372:216-223,180, Holmes,C.,et al., 2008

Primary Central Nervous System Vasculitis with Prominent Leptomeningeal Enhancement
Arthritis Rheum:58:595-603, Salvarani, C.,et al, 2008

PET of Brain Amyloid and Tau in Mild Cognitive Impairment
NEJM 355:2652-2663, Small,G.W.,et al, 2006

Neuroimaging and Early Diagnosis of Alzheimer Disease: A Look to the Future
Radiology 226:315-336, Petrella,J.R.,et al, 2003

Immunization for Alzheimer's Disease: A Shot in the Arm or a Whiff?
Ann Neurol 48:553-555, Levey,A.I., 2000

Apolipoprotein E, Dementia, and Cortical Deposition of B-Amyloid Protein
NEJM 333:1242-1247, 12831995., Polvikoski,T.,et al, 1995

Human Prion Diseases
Ann Neurol 35:385-395, Prusiner,S.B.&Hsiao,K.K., 1994

Clinicopath Conf
Spongiform Encephalopathy (Creutzfeldt-Jakob Disease) , with Amyloid (KURU) Plaques, Case 17-1993, N, JM 328:66,1993., 1993

The Molecular Pathogenesis of Alzheimer's Disease:Clinical Prospects
Lancet 340:1512-1515, Murphy,M., 1992

BA4 Amyloid Protein Deposition in Brain After Head Trauma
Lancet 338:1422-1423, Roberts,G.W.,et al, 1991

Amyloid A4 Protein and Its Precursor in Down's Syndrome and Alzheimer's Disease
NEJM 320:1446-1452, 1484-14861989., Rumble,B.,et al, 1989

Gerstmann-Straussler-Scheinker Disease, I, Extending the Clinical Spectrum
Neurol 39:1446-1452, Farlow,M.R.,et al, 1989

Gerstmann-Straussler-Scheinker Disease, II, Neurofibrillary Tangles & Plaques with PrP-amyloid in an Affected Family
Neurol 39:1453-1461, Ghetti,B.,et al, 1989

Brain Amyloid and Alzheimer Disease
Ann Int Med 109:41-54, Vinters,H.V.,et al, 1988

Prions & Neurodegenerative Diseases
NEJM 317:1571-1581, 15971987., Prusiner,S.B., 1987

Gerstmann-Straussler-Scheinker Disease:Autopsy Study of a Familial Case
Ann Neurol 20:540-543, Vinters,H.V.,et al, 1986

Creutzfeldt-Jakob Disease Prion Proteins in Human Brains
NEJM 312:73-78, Bockman,J.M.,et al, 1985

Gerstmann-Straussler-Scheinker Disease with Coincidental Familial Onset
Ann Neurol 14:670-678, Hudson,A.J.,et al, 1983

Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025

A 32 Year-Old Woman with Recurrent Intracerebral Hemorrhages
Neurol 104:e213422, Hindsholm,M.F.,et al, 2025

A 67 YEar-Old Woman with Progressive Headache, Visual Hallucinations, and Seizures
Neurol 104:e213496, Gheihman,G.,et al, 2025

Association Between Cerebral Amyloid Angiopathy and Nontraumatic Subdural Hemorrhage
Neurol 104:e213614, Andres,W.,et al, 2025

Cerebral Amyloid Angiopathy and Risk of Isolated Nontraumatic Subdural Hemorrhage
JAMA Neurol 81:163-169, Rivier,C.A.,et al, 2024

Diagnosing Cerebral Amyloid Angiopathy-Related Inflammation
Neurol 103:e209548, Charidimou,A., 2024

Occult Amyloid-B-Related Angiitis:Neuroimaging Findings at 1.5T, 3T, and 7T MRI
AJNR 45:1013-1018, Ozutemlz,C.,et al, 2024

CSF and Plasma Biomarkers in Patients with Iatrogenic Cerebral Amyloid Angiopathy
Neurol 103:e209828, Pollaci,G.,et al, 2024

Sulcal Hyperintensity as an Early Imaging Finding in Cerebral Amyloid Angiopathy-Related Inflammation
Neurol 103:e210084, Panteleienko,L.,et al, 2024

Amyloid-Related Imaging Abnormalities:An Update
AJR 220:562-575, Roytman,M.,et al, 2023

Clinical,Neuroimaging,and Genetic Markers in Cerebral Amyloid Angiopatny-Related Inflammation:A Systematic Review and Meta-Analusis
Stroke 54:178-188, Theodorou,A.,et al, 2023

Lecanemab in Early Alzheimers Disease
NEJM 388:9-21,80, van Dyck,A.H.,et al, 2023

Cortical Superficial Siderosis and Transient Focal Neurological Episode Preceding Lobar Hemorrhage in Cerebral Amyloid Angiopathy
Stroke 54:e48-e51, Therdorou,A.,et al, 2023

Blook Transfusion and Brain Amyloidosis, Should We Be Worried?
JAMA 330:921-922, Greenberg,S.M., 2023

Etiology of Primary Cerebellar Intracerebral Hemorrhage Based on Topographic Localization
Stroke 54:3074-3080, Incontri,D.,et al, 2023

Severe Amyloid-Related Imaging Abnormalities After Anti-B-Amyloid Monoclonal Antibody Treatment
Neurol 101:1079-1080, Bonami,S.,et al, 2023

Cerebral Amyloid Angiopathy-How to Translate Updated Diagnostic Criteria for this Multifaceted Disorder to Clinical Practice?
JAMA Neurol 80:225-226, Biessels,G.J., 2023

Antithrombotic Therapy in Patients with Cerebral Microbleeds or Cortical Siderosis, Is This Contraindicated?
Neurol 100:551-552, Schneck,M.J., &Biller,J., 2023



Showing articles 0 to 50 of 345 Next >>